**Background and objective:** The FilmArray Respiratory Panel 2 (RP2) is a multiplex in vitro diagnostic test for the simultaneous and rapid (∼45-min) detection of 22 pathogens directly from nasopharyngeal swab (NPS) samples. It contains updated (and in some instances redesigned) assays that improve upon the FilmArray Respiratory Panel (RP; version 1.7), with a faster run time. The organisms identified are adenovirus, coronavirus 229E, coronavirus HKU1, coronavirus NL63, coronavirus OC43, human metapneumovirus, human rhinovirus/enterovirus, influenza virus A, influenza virus A H1, influenza virus A H1-2009, influenza virus A H3, influenza virus B, parainfluenza virus 1, parainfluenza virus 2, parainfluenza virus 3, parainfluenza virus 4, respiratory syncytial virus, Bordetella pertussis, Chlamydia pneumoniae, and Mycoplasma pneumoniae Two new targets are included in the FilmArray RP2: Middle East respiratory syndrome coronavirus and Bordetella parapertussis.

In this study, we are evaluating the performance and accuracy of BioFire FilmArray in comparison to our gold standard method MERS-Cov using Roche MagnPure 96 and Light Cycler 480.

**Methods:** 25 clinical samples were tested parallel using both Roche Light Cycler then repeated by using Respiratory Multiplex Panel 2 and performed on BioFire FilmArray.

All tested samples were respiratory such as Sputum, Tracheal aspiration, Endotracheal, Nasopharyngeal aspiration and Nasopharyngeal Swabs.

**Result:** 25 Patient samples were tested for MERS CoV. Overall positive percent agreement between systems was 99% and the negative percent agreement was 95%.

**Conclusion:** In comparison with Roche Light Cycler, there were no false positive results observe from FilmArray system, which indicate that the FilmArray system design and effective in preventing carryover and cross contamination. However, we found that FilmArray system has more reliability and accuracy than Roche Light Cycler System. Moreover, easy to perform the test and the entire process takes about one hour, which dramatically changed the Turn-Around-Time to report the result.
